In addition, decreased BDNF levels/signaling have been implicated in neurodegenerative disorders including Alzheimer’s disease (AD), Parkinson’s disease (PD), and Huntington’s disease (HD) (Figure 3A). This evidence concerns the gene BDNF and early-onset autosomal dominant Alzheimer disease.